CYP2C9 and type 2 diabetes mellitus: As presented in Table 2, T2D had no effect on mRNA levels for all studied drug metabolizing enzymes (CYP450s and CES) (p-value > 0.05), even though a tendency was observed with increased CYP2C9 mRNAs (p = 0.051) in patients with T2D.